NOVONIX Limited (ASX:NVX)

NOVONIX Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Operating Revenue	5.62	5.85	8.05	5.4	6.1
Revenue	5.62	5.85	8.05	5.4	6.1
Revenue Growth (YoY)	-4.05%	-27.32%	49.03%	-11.42%	56.69%
Cost of Revenue	2.5	1.77	2.82	2.64	1.72
Gross Profit	3.12	4.08	5.24	2.77	4.38
Selling, General & Admin	45.09	49.08	44.83	50.77	39.86
Research & Development	5.67	4.85	5.75	4.04	5.1
Operating Expenses	55.33	58.49	55.32	59.96	49.18
Operating Income	-52.22	-54.41	-50.08	-57.19	-44.8
Interest Expense	-11.89	-3.54	-2.85	-1.83	-1.47
Interest & Investment Income	1.09	1.37	1.61	0.04	0.01
Currency Exchange Gain (Loss)	1.83	-1.18	1.36	2.72	5.2
Other Non Operating Income (Expenses)	8.77	-1.66	3.51	0.54	-2.68
EBT Excluding Unusual Items	-52.41	-59.42	-46.45	-55.73	-43.75
Gain (Loss) on Sale of Investments	-	-15.31	-	-	-8.11
Asset Writedown	-7.35	-	-	-	-
Other Unusual Items	-32.94	-	-	-	-
Pretax Income	-92.7	-74.72	-46.45	-55.73	-51.86
Income Tax Expense	0.03	0.1	-0.2	-	-
Net Income	-92.73	-74.82	-46.25	-55.73	-51.86
Net Income to Common	-92.73	-74.82	-46.25	-55.73	-51.86
Shares Outstanding (Basic)	682	497	487	487	464
Shares Outstanding (Diluted)	682	497	487	487	464
Shares Change (YoY)	37.20%	1.93%	0.18%	4.78%	26.80%
EPS (Basic)	-0.14	-0.15	-0.09	-0.11	-0.11
EPS (Diluted)	-0.14	-0.15	-0.09	-0.12	-0.11
Free Cash Flow	-102.38	-70.32	-55.42	-86.76	-112.99
Free Cash Flow Per Share	-0.15	-0.14	-0.11	-0.18	-0.24
Gross Margin	55.49%	69.76%	65.02%	51.16%	71.73%
Operating Margin	-929.63%	-929.39%	-621.75%	-1058.22%	-734.29%
Profit Margin	-1650.76%	-1278.04%	-574.19%	-1031.13%	-850.01%
Free Cash Flow Margin	-1822.69%	-1201.22%	-688.11%	-1605.40%	-1851.97%
EBITDA	-48.32	-50.46	-45.77	-52.48	-41.02
D&A For EBITDA	3.9	3.95	4.31	4.71	3.78
EBIT	-52.22	-54.41	-50.08	-57.19	-44.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.